Literature DB >> 22028304

A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.

Christopher T Esapa1, Tertius A Hough, Sarah Testori, Rosie A Head, Elizabeth A Crane, Carol P S Chan, Holly Evans, J H Duncan Bassett, Przemko Tylzanowski, Eugene G McNally, Andrew J Carr, Alan Boyde, Peter G T Howell, Anne Clark, Graham R Williams, Matthew A Brown, Peter I Croucher, M Andrew Nesbit, Steve D M Brown, Roger D Cox, Michael T Cheeseman, Rajesh V Thakker.   

Abstract

Progeny of mice treated with the mutagen N-ethyl-N-nitrosourea (ENU) revealed a mouse, designated Longpockets (Lpk), with short humeri, abnormal vertebrae, and disorganized growth plates, features consistent with spondyloepiphyseal dysplasia congenita (SEDC). The Lpk phenotype was inherited as an autosomal dominant trait. Lpk/+ mice were viable and fertile and Lpk/Lpk mice died perinatally. Lpk was mapped to chromosome 15 and mutational analysis of likely candidates from the interval revealed a Col2a1 missense Ser1386Pro mutation. Transient transfection of wild-type and Ser1386Pro mutant Col2a1 c-Myc constructs in COS-7 cells and CH8 chondrocytes demonstrated abnormal processing and endoplasmic reticulum retention of the mutant protein. Histology revealed growth plate disorganization in 14-day-old Lpk/+ mice and embryonic cartilage from Lpk/+ and Lpk/Lpk mice had reduced safranin-O and type-II collagen staining in the extracellular matrix. The wild-type and Lpk/+ embryos had vertical columns of proliferating chondrocytes, whereas those in Lpk/Lpk mice were perpendicular to the direction of bone growth. Electron microscopy of cartilage from 18.5 dpc wild-type, Lpk/+, and Lpk/Lpk embryos revealed fewer and less elaborate collagen fibrils in the mutants, with enlarged vacuoles in the endoplasmic reticulum that contained amorphous inclusions. Micro-computed tomography (CT) scans of 12-week-old Lpk/+ mice revealed them to have decreased bone mineral density, and total bone volume, with erosions and osteophytes at the joints. Thus, an ENU mouse model with a Ser1386Pro mutation of the Col2a1 C-propeptide domain that results in abnormal collagen processing and phenotypic features consistent with SEDC and secondary osteoarthritis has been established.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22028304     DOI: 10.1002/jbmr.547

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  16 in total

1.  Mechanobiological Mechanisms of Load-Induced Osteoarthritis in the Mouse Knee.

Authors:  Olufunmilayo O Adebayo; Derek T Holyoak; Marjolein C H van der Meulen
Journal:  J Biomech Eng       Date:  2019-07-01       Impact factor: 2.097

Review 2.  Collagen misfolding mutations: the contribution of the unfolded protein response to the molecular pathology.

Authors:  John F Bateman; Matthew D Shoulders; Shireen R Lamandé
Journal:  Connect Tissue Res       Date:  2022-02-26       Impact factor: 3.417

3.  SEMA6D, Negatively Regulated by miR-7, Contributes to C28/I2 chondrocyte's Catabolic and Anabolic Activities via p38 Signaling Pathway.

Authors:  Haoyu Yang; Zhicheng Yang; Zhentang Yu; Chenwei Xiong; Yi Zhang; Junjie Zhang; Yong Huang; Xindie Zhou; Jin Li; Nanwei Xu
Journal:  Oxid Med Cell Longev       Date:  2022-06-16       Impact factor: 7.310

4.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

5.  A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation.

Authors:  Sian E Piret; Christopher T Esapa; Caroline M Gorvin; Rosie Head; Nellie Y Loh; Olivier Devuyst; Gethin Thomas; Steve D M Brown; Matthew Brown; Peter Croucher; Roger Cox; Rajesh V Thakker
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

6.  Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma.

Authors:  Yasushi Totoki; Akihiko Yoshida; Fumie Hosoda; Hiromi Nakamura; Natsuko Hama; Koichi Ogura; Aki Yoshida; Tomohiro Fujiwara; Yasuhito Arai; Junya Toguchida; Hitoshi Tsuda; Satoru Miyano; Akira Kawai; Tatsuhiro Shibata
Journal:  Genome Res       Date:  2014-07-14       Impact factor: 9.043

7.  Alteration of proteoglycan sulfation affects bone growth and remodeling.

Authors:  Benedetta Gualeni; Marie-Christine de Vernejoul; Caroline Marty-Morieux; Fabio De Leonardis; Marco Franchi; Luca Monti; Antonella Forlino; Pascal Houillier; Antonio Rossi; Valerie Geoffroy
Journal:  Bone       Date:  2013-01-28       Impact factor: 4.398

8.  A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.

Authors:  Christopher T Esapa; Rosie A Head; Jeshmi Jeyabalan; Holly Evans; Tertius A Hough; Michael T Cheeseman; Eugene G McNally; Andrew J Carr; Gethin P Thomas; Matthew A Brown; Peter I Croucher; Steve D M Brown; Roger D Cox; Rajesh V Thakker
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

9.  Endoplasmic reticulum stress-unfolding protein response-apoptosis cascade causes chondrodysplasia in a col2a1 p.Gly1170Ser mutated mouse model.

Authors:  Guoyan Liang; Chengjie Lian; Di Huang; Wenjie Gao; Anjing Liang; Yan Peng; Wei Ye; Zizhao Wu; Peiqiang Su; Dongsheng Huang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth.

Authors:  Benedetta Gualeni; M Helen Rajpar; Aaron Kellogg; Peter A Bell; Peter Arvan; Raymond P Boot-Handford; Michael D Briggs
Journal:  Dis Model Mech       Date:  2013-09-12       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.